stocknews1h
3 Biotech Innovators Advancing Genetic Therapies
The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...
Orna Therapeutics, Vertex Pharma Enter Three-year Research Collaboration - Quick Facts
Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...
The Pharma Letter2h
Vertex has CF cornered, but won’t stop till every patient feels the same
Unquestionably, US drugmaker Vertex Pharmaceuticals is the dominant drug developer in the cystic fibrosis (CF) space. How has ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by CWA Asset Management Group LLC
CWA Asset Management Group LLC trimmed its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) ...
Bernstein Remains a Hold on Vertex Pharmaceuticals (VRTX)
Bernstein analyst William Pickering maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target of ...
Nordea Investment Management AB Purchases 55,739 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Nordea Investment Management AB increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.4% during the fourth quarter, Holdings Channel reports. The ...
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $402.49, representing a -1.13% change from its previous close.
Why AI Chip Stocks Broadcom, Marvell, and Arm Holdings Rallied Again Today
AI-related chip stocks sold off a bit during the last couple of weeks of 2024, but they got a lift Friday on signs of strong ...